Europe World Orphan Drug Congress 2025

World Orphan Drug Congress Europe will be held from 27–29 October 2025 at RAI Amsterdam, Netherlands, bringing together over 2,000 attendees, 250 speakers, and 130+ exhibitors from across the global rare disease community. The event spans the entire orphan drug lifecycle — from regulation, policy, and pricing to gene therapy development, clinical trials, and patient advocacy. Organized by Terrapinn Holdings, the congress serves as the leading platform for collaboration, networking, and knowledge exchange among industry innovators, researchers, and regulators working to advance treatment access and accelerate breakthroughs in rare diseases.

Range of Exhibition

• Cell & Gene Therapies:
  Gene therapy development, genetic testing, gene editing, and advanced cell-based treatment solutions.
• Market Access & Policy:
  Global pricing and reimbursement, orphan drug policy, epidemiology, forecasting, and value-based healthcare models.
• Research & Clinical Development:
  Clinical trial design, manufacturing innovations, real-world evidence generation, and expanded access programs.
• Investment & Partnership:
  Partnering platforms, funding opportunities, and strategic collaborations across the rare disease ecosystem.
• Patient Advocacy & Support:
  Global patient networks, advocacy initiatives, and stakeholder engagement for improving patient outcomes.

Target Audience

Pharmaceutical manufacturers, biotech startups, research scientists, healthcare policymakers, patient advocacy groups, clinical trial specialists, regulatory professionals, healthcare investors, gene and cell therapy developers, and pricing and reimbursement consultants.